| Project title |
Preclinical Evaluation of a Novel Neurotherapeutic for ALS |
| Summary |
Principal Investigator |
| Funding Agency |
Fondation Thierry Latran |
| Programme |
|
| Type of Project |
Research Project |
| Date from |
2011 |
| Date to |
2012 |
| Person Months |
12 |
|
|
| Project title |
Determining beneficial effects of a new therapeutic compound, JAK4D, in the SOD1 mouse model of Amyotrophic Lateral Sclerosis (ALS) |
| Summary |
€128,500 Principal Investigator |
| Funding Agency |
Irish Motor Neurone Disease Research Foundation |
| Programme |
|
| Type of Project |
Research Project |
| Date from |
2009 |
| Date to |
2011 |
| Person Months |
24 |
|
|
| Project title |
Development of a Novel Compound for treating Neurological Disorders. |
| Summary |
€392,415
Principal
Investigator (PI)
|
| Funding Agency |
Enterprise Ireland CFTD/2006/122 |
| Programme |
|
| Type of Project |
|
| Date from |
2007 |
| Date to |
2009 |
| Person Months |
|
|
|
| Project title |
Parenteral delivery system for first in class compound with potential therapeutic application in CNS disorders. |
| Summary |
€85,025 (2006-2007)
Principal Investigator (PI)
|
| Funding Agency |
Enterprise Ireland |
| Programme |
Enterprise Ireland PC/2005/201 |
| Type of Project |
|
| Date from |
2006 |
| Date to |
2007 |
| Person Months |
|
|
|
| Project title |
Furthering the development of potent thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE inhibitors – toward a novel therapeutic strategy for CNS disorders. |
| Summary |
€238,703 (2005-2008) [Principal Investigator (PI)]
|
| Funding Agency |
HRB Project Grant RP/2005/152 |
| Programme |
|
| Type of Project |
|
| Date from |
2005 |
| Date to |
2008 |
| Person Months |
|
|
|
| More Research Projects>>> |
| Campbell M, Kiang AS, Kenna PF, Kerskens C, Blau C, O'Dwyer L, Tivnan A, Kelly JA, Brankin B, Farrar GJ, Humphries P. , RNAi-mediated reversible opening of the blood-brain barrier. , Journal of Gene Medicine, 10, (8), 2008, p930 - 947 |
Kelly JA, Scalabrino GA, Slator GR, Cullen AA, Gilmer JF, Lloyd DG, Bennett GW, Bauer K, Tipton KF, Williams CH., Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II, Biochem J., 389, (Pt 2), 2005, p569 - 576 Notes: [PMID: 15799721] |
Kelly JA, Slator GR, O’Boyle KM., Pharmacological distinct binding sites in rat brain for [3H]-thyrotropin-releasing hormone (TRH) and [3H][3-methyl-histidine2]TRH, Biochem. Pharmacol., 63, (12), 2002, p2197 - 2206 Notes: [PMID: 12110379] |
Papadopoulos T, Kelly JA, Bauer K., Mutational analysis of the thyrotropin-releasing hormone-degrading ectoenzyme. Similarities and differences with other members of the M1 family of aminopeptidases and thermolysin, Biochemistry, 40, 2001, p9347 - 9355 Notes: [PMID: 11478903] |
Kelly JA, Slator GR, Tipton KF, Williams CH, Bauer K., Kinetic investigation of the specificity of porcine brain thyrotropin-releasing hormone-degrading ectoenzyme for thyrotropin-releasing hormone-like peptides, J. Biol. Chem., 275, (22), 2000, p16746 - 16751 Notes: [PMID: 10748219] |
| More Publications>>> |
Contact:helpdesk@tcd.ie Last Updated:12-FEB-2012 |